Dr. Carl Friedrich Classen

University Children’s Hospital Rostock, Germany

Email: [email protected]

Qualifications

1989 Ph.D., Luebeck University, pediatrics

Publications (selected)

1. Rafaelian, A., Won, S. Y., Mueller, L., et al. (2026). Emergency reversal of Rivaroxaban with Andexanet alfa in a child with hemorrhagic brain metastasis from Wilms tumor. Child's Nervous System, 42(1), Article 195.
2. Schneider, B., Redwanz, C., Celis, V., et al. (2026). miRNA profiling in pediatric and young adult Burkitt leukemia and lymphoma. Virchows Archiv.
3. Sarais, F., Krempien, F., Koehn, C., et al. (2025). Targeting PP2A in cancer: an underrated option. Journal of Experimental & Clinical Cancer Research, 44(1), Article 295.
4. Shokraie, F., Lechermeier, L., Bordihn, P., et al. (2025). CDK inhibitors promote neuroblastoma cell differentiation and increase sensitivity to retinoic acid-a promising combination strategy for therapeutic intervention. Cell Death Discovery, 11(1), Article 363.
5. Rode, S., Gerds, S., Thiem, A., et al. (2025). Intertriginous eczema in a child? - Diagnosis: Langerhans cell histiocytosis (LZH). Journal der Deutschen Dermatologischen Gesellschaft, 23(Suppl 5), 17–18.
6. Seidel, D., Pana, Z. D., Ebrahimi-Fakhari, D., et al. (2025). Approaches to Invasive Fungal Diseases in Paediatric Cancer Centres: An Analysis of Current Practices and Challenges in Germany, Austria and Switzerland. Mycoses, 68(6), Article e70074.
7. Faerber, J., Köhn, C., Maletzki, C., et al. (2025). TMZ Sensitization in GBM Cell Lines by Sequential Fadraciclib Treatment: An MGMT-Independent Strategy. Klinische Pädiatrie, 237(3), 179–179.
8. Riedmeier, M., Idkowiak, J., Frey, H., et al. (2025). Inflammation-based score in pediatric adrenocortical carcinoma. Endocrine-Related Cancer, 32(5), Article e240244.
9. Schneider, B., Redwanz, C., Celis, V., et al. (2025). miRNA signatures in Burkitt leukemia and lymphoma in children and young adults. Klinische Pädiatrie, 237(3), 181–181.
10. Cardesa-Salzmann, T. M., Sparber-Sauer, M., Hingst, P., et al. (2025). On TRacK With Larotrectinib in a Neonate With a Giant Congenital ETV6::NTRK3 Fusion-Positive Infantile Fibrosarcoma of the Head and Neck. Head & Neck, 47(5), E50–E57.
11. Abla, O., Picarsic, J., Emile, J. F., et al. (2024). Treatment Strategies and Outcomes of the Rare Histiocytic Disorders: Long-Term Results of the International Rare Histiocytic Disorders Registry (IRHDR). Blood, 144(Suppl 1), 3909–3910.
12. von Grundherr, J., Elmers, S., Koch, B., et al. (2024). A Multimodal Lifestyle Psychosocial Survivorship Program in Young Cancer Survivors. JAMA Network Open, 7(3), Article e242375.
13. Flaadt, T., Wild, H., Abele, M., et al. (2024). NUT carcinoma in pediatric patients: Characteristics, therapeutic regimens, and outcomes of 11 cases registered with the German Registry for Rare Pediatric Tumors (STEP). Pediatric Blood & Cancer, 71(3), e30821.
14. Classen, C. F. (2023). ALK-POSITIVE NON-LANGERHANS CELL HISTIOCYTOSIS - THE GERMAN COLLECTION AND CONSULTATION SERVICE. Pediatric Blood & Cancer, 70(Suppl 8).
15. Rehbein, S., Possmayer, A. L., Bozkurt, S., et al. (2023). Molecular Determinants of Calcitriol Signaling and Sensitivity in Glioma Stem-like Cells. Cancers, 15(21), Article 5249.
16. Lechermeier, L., Shokraie, F., Freitag, T., et al. (2023). Retinoic acid and CDK-inhibitors cooperate in differentiation of neuroblastoma cells. Oncology Research and Treatment, 46(Suppl 5), 132–133.
17. Lehrnbecher, T., Ahlmann, M., Albert, M., et al. (2023). Updated AWMF guidelines for the diagnosis and treatment of Langerhans cell histiocytosis (LCH) in children and adolescents. Klinische Pädiatrie, 235(6), 322–330.
18. Linke, C., Freitag, T., Riess, C., et al. (2023). The addition of arginine deiminase potentiates Mithramycin A-induced cell death in patient-derived glioblastoma cells via ATF4 and cytochrome C. Cancer Cell International, 23(1), Article 2873.
19. Abla, O., Picarsic, J., Emile, J. F., et al. (2023). TREATMENT OUTCOMES OF THE RARE HISTIOCYTIC DISORDERS: FIRST DESCRIPTIVE ANALYSIS OF THE IRHDR-REGISTRY. Pediatric Blood & Cancer, 70(Suppl 1), S1–S1.
20. Classen, C. F. (2023). THE GERMAN RARE HISTIOCYTOSES REGISTRY AND CONSULTATION - EXPERIENCES IN ROSAI DORFMAN DISEASE CASES. Pediatric Blood & Cancer, 70(Suppl 1), S8–S9.

Profile Details
https://www.erdheim-chester.org/doctor/prof-carl-friedrich-classen-md/
https://www.researchgate.net/scientific-contributions/Carl-Friedrich-Classen-2050421401
https://loop.frontiersin.org/people/134643/bio

WOS ResearcherID: ESH-5253-2022